Home » Topics » BioWorld

BioWorld
RSS

ENZON TO CO-DEVELOP CANCER TREATMENT

Jan. 27, 1992

PROTEIN POLYMER RAISES $9.4M IN IPO

Jan. 27, 1992

FEVERISH IPO WEEK CLOSES ON TARGET

Jan. 27, 1992

DEPRENYL BOARD RECOMMENDS STOCK SPLIT

Jan. 27, 1992

GENZYME PROTEIN DESIGNATED ORPHAN

Jan. 24, 1992

IAF COMPLETES DEAL WITH GLAXO

Jan. 24, 1992

CLINICAL TECHNOLOGIES CHANGES NAME

Jan. 24, 1992

VIMRX RAISES $5 MILLION IN OFFERING

Jan. 24, 1992

FIELD TEST GUIDELINES BEING REVIEWED

Jan. 24, 1992

CHIRON SUES FOR PATENT INFRINGEMENT

Jan. 24, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...